ATAI Life Sciences N.V [NASDAQ: ATAI] stock went on a downward path that fall over -0.72% on Monday, amounting to a one-week price increase of more than 25.00%.
Over the last 12 months, ATAI stock rose by 106.77%. The one-year ATAI Life Sciences N.V stock forecast points to a potential upside of 73.04. The average equity rating for ATAI stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $552.07 million, with 199.78 million shares outstanding and 137.08 million shares in the current float. Compared to the average trading volume of 3.15M shares, ATAI stock reached a trading volume of 8008593 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on ATAI Life Sciences N.V [ATAI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATAI shares is $10.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATAI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for ATAI Life Sciences N.V shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 18, 2024. The new note on the price target was released on April 03, 2024, representing the official price target for ATAI Life Sciences N.V stock. Previously, the target price had yet another raise to $18, while Loop Capital analysts kept a Buy rating on ATAI stock.
The Price to Book ratio for the last quarter was 3.61, with the Price to Cash per share for the same quarter was set at 0.54.
ATAI Stock Performance Analysis:
ATAI Life Sciences N.V [ATAI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.00. With this latest performance, ATAI shares gained by 11.34% in over the last four-week period, additionally plugging by 106.77% over the last 6 months – not to mention a rise of 106.77% in the past year of trading.
Insight into ATAI Life Sciences N.V Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and ATAI Life Sciences N.V [ATAI] shares currently have an operating margin of -31987.01% and a Gross Margin at -5.44%. ATAI Life Sciences N.V’s Net Margin is presently recorded at -38852.87%.
Return on Equity for this stock declined to -50.86%, with Return on Assets sitting at -50.86%.
ATAI Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ATAI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ATAI Life Sciences N.V go to 29.93%.
ATAI Life Sciences N.V [ATAI] Institutonal Ownership Details
There are presently around $33.40%, or 36.39% of ATAI stock, in the hands of institutional investors. The top three institutional holders of ATAI stocks are: WALLEYE CAPITAL LLC with ownership of 2.76 million shares, which is approximately 1.7226%. MORGAN STANLEY, holding 2.72 million shares of the stock with an approximate value of $$3.62 million in ATAI stocks shares; and MORGAN STANLEY, currently with $$1.74 million in ATAI stock with ownership which is approximately 0.8148%.
